Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCR | P30988 | 5/20 | 0.68 |
| ▸ | NPY2R | P49146 | 8/20 | 0.66 |
| ▸ | NPY4R | P50391 | 8/20 | 0.66 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.66 |
| ▸ | NPY1R | P25929 | 6/20 | 0.66 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.65 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.65 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.64 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.64 |
| ▸ | F2 | P00734 | 3/20 | 0.64 |
| ▸ | RAMP1 | O60894 | 1/20 | 0.63 |
| ▸ | RAMP2 | O60895 | 1/20 | 0.63 |
| ▸ | RAMP3 | O60896 | 1/20 | 0.63 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31182486 | 0.96 | CALCR (0.69) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL31182495 | 0.94 | NPY2R (0.70) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL29949425 | 0.94 | CALCR (0.67) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30932056 | 0.93 | NPY2R (0.68) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30932058 | 0.93 | NPY2R (0.68) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30932059 | 0.93 | NPY2R (0.68) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30932084 | 0.93 | NPY2R (0.68) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30495828 | 0.93 | CALCR (0.74) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL29525286 | 0.93 | NPY2R (0.68) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL29800193 | 0.93 | NPY2R (0.69) | CALCRNPY2RNPY4RNPY5RNPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109983026-B | Carrier for mixed mode affinity chromatography | 富士胶片株式会社 | 2023-09-19 | — | — | CN | disclosed |
| US-11565240-B2 | Mixed mode affinity chromatography carrier | FUJIFILM CORPORATION (JP) | 2023-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11565240-B2 | Mixed mode affinity chromatography carrier | FCGR2A, FCGR3B, FCGR1A | CALCR 2142/4885NPY2R 2601/4885NPY4R 1703/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.